Navigation Links
FDA Approves First Drug to Prevent Premature Births
Date:2/7/2011

those women."

Hydroxyprogesterone caproate has not been without some controversy. In 2006, an FDA advisory committee considering hydroxyprogesterone caproate to treat preterm birth brought up safety concerns, including a possible association with second trimester miscarriages.

Hydroxyprogesterone caproate is also the same drug as a much older one called Delalutin, which was approved by the FDA in 1956 and was used to treat female hormone disturbances and cancer, but withdrawn from the market for business reasons in 2008, the agency says.

"Makena is chemically the same as Delalutin," Burgess said.

What is new here is that a drug company will be making the drug; it won't have to be made up in pharmacies, according to Fleischman. "There will be consistency and high quality. This makes it a breakthrough not only that it's FDA approved and doctors will be comfortable in recommending it, but also there will be high quality and consistency for women as they take it," he said.

Dr. Gene Burkett, a professor of obstetrics and gynecology at the University of Miami Miller School of Medicine said that "this is something we have been using with women prone to preterm labor. It has been almost a standard of care for the last five or six years."

"Makena was approved under FDA's accelerated approval regulations, which allow promising drugs to be approved based on showing a benefit on a 'surrogate endpoint' that is likely to predict an actual clinical benefit," Burgess said. In this case, it was reducing the risk of delivery before 37 weeks.

Part of the terms of this approval require the manufacturer to conduct studies that demonstrate that the drug has a clinical benefit, she said.

In making its decision, the FDA reviewed data on the safety and effectiveness of Makena from a clinical trial that included 463 pregnant women who had a history of a spontaneous preterm birth.

Among those receiving Makena, 37 percent delivered be
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Swiss agency approves clinical trial of UCI-created neural stem cell therapy
2. ACGME board approves final duty hour and supervision standards for resident education
3. FDA Approves 1st Oral Drug to Reduce MS Relapses
4. FDA approves Merz Pharmaceuticals Xeomin (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasm
5. Early detection of cancer: The FDA approves procedure discovered by EPFL researchers
6. FDA approves first human neural stem cell clinical trial to treat brain tumors
7. FDA Approves Stemedica IND for Ischemic Stroke Clinical Trial
8. New York State Office of Mental Health Approves New High Performance Polycarbonate Sheet for Use in All Facilities
9. House of Representatives Approves Health-Care Reform Bill
10. Congress Approves Bill Curbing Internet Tobacco Sales in Victory for Kids and Taxpayers
11. New Jersey Approves Initiative to Expand the Number of Wound Care Certified Professionals
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Approves First Drug to Prevent Premature Births 
(Date:11/26/2014)... November 26, 2014 Louisiana Back ... and specialists in minimally invasive spine surgery, announces ... into the rapidly growing provider network of orthopedic ... addition coincides with the network’s continuing success providing ... for Louisiana residents who are suffering from orthopedic ...
(Date:11/26/2014)... Sonoran Vein and Endovascular nurse, ... Distinguished Preceptorship Award from The American Association ... the advancement of nurse practitioners. The Distinguished Preceptorship ... had made a significant contribution toward increasing the ... of Nurse Practitioners (AANP) is the largest full-service ...
(Date:11/26/2014)... Youngsters who enter puberty early are at increased risk ... was linked with a number of factors associated with ... according to the researchers. Early puberty was also linked ... peers, and having friends who were prone to getting ... found an association between early puberty and these factors, ...
(Date:11/26/2014)... -- Teens prescribed anti-anxiety or sleep medications are ... other teens, a new study warns. The ... assessments on teenagers before prescribing these drugs to ... don,t realize the abuse potential," said lead researcher ... Michigan School of Nursing. "These drugs produce highly ...
(Date:11/26/2014)... News) -- Exposure to peanut protein in household dust ... with the skin condition eczema, a new study reveals. ... United States are allergic to peanuts. And severe eczema ... peanut allergy, the researchers noted. The new study ... The researchers examined the amount of peanut protein the ...
Breaking Medicine News(10 mins):Health News:Louisiana Back Institute Welcomes Dr. K. Samer Shamieh into Medical Provider Network 2Health News:Sonoran Nurse Receives Distinguished Preceptorship Award from The American Association of Nurse Practitioners 2Health News:Early Puberty Linked to Increased Risk of Depression in Teens 2Health News:Teens Given Anxiety, Sleep Meds May Be at Risk for Drug Abuse 2Health News:Infants With Eczema May Be More Prone to Peanut Allergy: Study 2
... Volunteers trained on moveable platform kept better balance in ... -- Repeatedly exposing people to situations where the footing ... on slippery floors and avoid falls, says a University ... improves understanding of how the brain develops fall prevention ...
... Feb. 20 /PRNewswire-FirstCall/ -. Alsius Corporation,(Nasdaq: ... an agreement with a wholly-,owned subsidiary of ZOLL ... which Alsius,will sell to ZOLL substantially all the ... a purchase price of,$12 million in cash. ...
... Abbott ( NYSE: ABT ) today announced that it ... for its acquisition of Advanced Medical Optics (AMO) through ... common stock of AMO. The European Commission approved ... tender offer related to European Commission regulatory approval and ...
... China Healthcare Acquisition Corp. (the "Company") (NYSE ... Board of Directors has set March 5, 2009 as ... to receive liquidating distributions from the trust fund established ... public offering (the "IPO") and into which the net ...
... Feb. 20 Endo Pharmaceuticals (Nasdaq: ENDP ... announced today that the companies have settled litigation with ... of generic formulations of Opana(R) ER (oxymorphone hydrochloride) Extended ... to dismiss their suit with prejudice and Actavis has ...
... identify those at risk and tailor treatment methods , , FRIDAY, ... may explain why some people are more heavily dependent on ... Health System researchers linked the DNA sequencing of the SLC6A4 ... receiving help for alcohol dependency used to have. Serotonin, a ...
Cached Medicine News:Health News:Adapting Gait May Help Elderly Avoid Falls 2Health News:Alsius Corporation Announces Agreement to Sell Assets to ZOLL Medical Corporation 2Health News:Alsius Corporation Announces Agreement to Sell Assets to ZOLL Medical Corporation 3Health News:Abbott Receives European Commission Clearance on Acquisition of Advanced Medical Optics 2Health News:Abbott Receives European Commission Clearance on Acquisition of Advanced Medical Optics 3Health News:China Healthcare Acquisition Announces Record Date for Trust Fund Distribution 2Health News:Endo and Penwest Announce Settlement of Opana(R) ER Litigation 2Health News:Endo and Penwest Announce Settlement of Opana(R) ER Litigation 3Health News:Endo and Penwest Announce Settlement of Opana(R) ER Litigation 4Health News:Gene Variant Tied to Severity of Drinking 2
(Date:11/26/2014)... , Nov. 26, 2014 The medical ... a rate of 4%, with world market revenues ... Information. MRI and other types of medical imaging ... treatment of numerous medical conditions in children and ... techniques. Kalorama,s report, Medical Imaging Markets , ...
(Date:11/26/2014)... 25, 2014  At the American Dental Association,s Annual ... October, KaVo Kerr Group was honored to be part ... the opportunity to see and test the Best of ... deliver lectures on the latest developments in dental technology. ... new DEXIS CariVu Caries Detection Device and Kerr Demi ...
(Date:11/26/2014)...  Medtronic,s roughly $43 billion acquisition and ... in the media for its US Federal tax ... player in one of the fastest growing device ... research firm said  the two companies compete in ... of solutions spanning inpatient to home care, and ...
Breaking Medicine Technology:Kalorama: Steady Growth in the Medical MRI Market 2Kalorama: Steady Growth in the Medical MRI Market 3KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 3Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 2Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 3
... Plume-inator produces the strongest vacuum ... smoke evacuators. The unit ... hospital grade plug, footswitch, built-in ... purpose swing ring to hold ...
A system for the removal and filtration of laser and surgical smoke....
Stryker Instruments, the leader in surgical helmets, offers its 4th generation of personal protection systems for todays surgical environment the Sterishield T4 System....
... The PS Medical Strata valve is ... the resistance properties of the valve can ... is designed to minimize overdrainage of cerebrospinal ... within a normal physiologic range, regardless of ...
Medicine Products: